Citation: S. Sugiyama et al., IMPLICATION OF THE GLYCOXIDATION AND LIPOXIDATION REACTIONS IN THE PATHOGENESIS OF DIALYSIS-RELATED AMYLOIDOSIS (REVIEW), INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2(5), 1998, pp. 561-565
Authors:
AYUTHAYA PIN
INAGI R
AUWANIT W
WARACHIT P
WESSAGOWIT V
UNGPAKORN R
LOAPHOOMPHAN N
PIRADHAMMANON P
YAMANISHI K
Citation: Pin. Ayuthaya et al., THE ASSOCIATION OF SKIN DISEASES WITH HUMAN-HERPESVIRUS-8 INFECTION IN HIV CARRIERS, Archives of virology, 143(10), 1998, pp. 1881-1892
Authors:
MORI Y
YAGI H
SHIMAMOTO T
ISEGAWA Y
SUNAGAWA T
INAGI R
KONDO K
TANO Y
YAMANISHI K
Citation: Y. Mori et al., ANALYSIS OF HUMAN-HERPESVIRUS-6 U3 GENE, WHICH IS A POSITIONAL HOMOLOG OF HUMAN CYTOMEGALOVIRUS UL-24 GENE, Virology (New York, N.Y. Print), 249(1), 1998, pp. 129-139
Authors:
MIYATA T
NANGAKU M
SUZUKI D
INAGI R
URAGAMI K
SAKAI H
OKUBO K
KUROKAWA K
Citation: T. Miyata et al., A MESANGIUM-PREDOMINANT GENE, MEGSIN, IS A NEW SERPIN UNREGULATED IN IGA NEPHROPATHY, The Journal of clinical investigation, 102(4), 1998, pp. 828-836
Authors:
MIYATA T
INAGI R
ASAHI K
YAMADA Y
HORIE K
SAKAI H
UCHIDA K
KUROKAWA K
Citation: T. Miyata et al., GENERATION OF PROTEIN CARBONYLS BY GLYCOXIDATION AND LIPOXIDATION REACTIONS WITH AUTOXIDATION PRODUCTS OF ASCORBIC-ACID AND POLYUNSATURATEDFATTY-ACIDS, FEBS letters, 437(1-2), 1998, pp. 24-28
Authors:
SUZUKI Y
INAGI R
AONO T
YAMANISHI K
SHIOHARA T
Citation: Y. Suzuki et al., HUMAN-HERPESVIRUS-6 INFECTION AS A RISK FACTOR FOR THE DEVELOPMENT OFSEVERE DRUG-INDUCED HYPERSENSITIVITY SYNDROME, Archives of dermatology, 134(9), 1998, pp. 1108-1112
Authors:
TOHYAMA M
YAHATA Y
YASUKAWA M
INAGI R
URANO Y
YAMANISHI K
HASHIMOTO K
Citation: M. Tohyama et al., SEVERE HYPERSENSITIVITY SYNDROME DUE TO SULFASALAZINE ASSOCIATED WITHREACTIVATION OF HUMAN-HERPESVIRUS-6, Archives of dermatology, 134(9), 1998, pp. 1113-1117
Authors:
INAGI R
KOSUGE H
NISHIMOTO S
YOSHIKAWA K
YAMANISHI K
Citation: R. Inagi et al., KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS (KSHV) SEQUENCES IN PREMALIGNANT AND MALIGNANT SKIN TUMORS, Archives of virology, 141(11), 1996, pp. 2217-2223
Authors:
TAKEDA K
NAKAGAWA N
YAMAMOTO T
INAGI R
KAWANISHI K
ISEGAWA Y
YAMANISHI K
Citation: K. Takeda et al., PROKARYOTIC EXPRESSION OF AN IMMEDIATE-EARLY GENE OF HUMAN HERPESVIRUS-6 AND ANALYSIS OF ITS VIRAL-ANTIGEN EXPRESSION IN HUMAN-CELLS, Virus research, 41(2), 1996, pp. 193-200
Authors:
INAGI R
GUNTAPONG R
NAKAO M
ISHINO Y
KAWANISHI K
ISEGAWA Y
YAMANISHI K
Citation: R. Inagi et al., HUMAN HERPESVIRUS-6 INDUCES IL-8 GENE-EXPRESSION IN HUMAN HEPATOMA-CELL LINE, HEP G2, Journal of medical virology, 49(1), 1996, pp. 34-40
Citation: R. Inagi et al., EVALUATION OF THE PROTEOLYTIC ACTIVITY OF FACTOR-D ACCUMULATED AS AN ACTIVE SERINE-PROTEASE IN PATIENTS WITH CHRONIC-RENAL-FAILURE, Nephron, 66(3), 1994, pp. 285-290
Authors:
MIYATA T
INAGI R
IIDA Y
SATO M
YAMADA N
ODA O
MAEDA K
SEO H
Citation: T. Miyata et al., INVOLVEMENT OF BETA(2)-MICROGLOBULIN MODIFIED WITH ADVANCED GLYCATIONEND-PRODUCTS IN THE PATHOGENESIS OF HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS - INDUCTION OF HUMAN MONOCYTE CHEMOTAXIS AND MACROPHAGE SECRETION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1, The Journal of clinical investigation, 93(2), 1994, pp. 521-528
Authors:
MIYATA T
INAGI R
WADA Y
UEDA Y
IIDA Y
TAKAHASHI M
TANIGUCHI N
MAEDA K
Citation: T. Miyata et al., GLYCATION OF HUMAN BETA-(2)-MICROGLOBULIN IN PATIENTS WITH HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS - IDENTIFICATION OF THE GLYCATED SITES, Biochemistry, 33(40), 1994, pp. 12215-12221
Authors:
IIDA Y
MIYATA T
INAGI R
SUGIYAMA S
MAEDA K
Citation: Y. Iida et al., BETA(2)-MICROGLOBULIN MODIFIED WITH ADVANCED GLYCATION END-PRODUCTS INDUCES INTERLEUKIN-6 FROM HUMAN MACROPHAGES - ROLE IN THE PATHOGENESISOF HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS, Biochemical and biophysical research communications, 201(3), 1994, pp. 1235-1241
Authors:
MIYATA T
FUJITA Y
INAGI R
INOUE I
SUGIYAMA S
MAEDA K
Citation: T. Miyata et al., EFFECTIVENESS OF NAFAMOSTAT MESILATE ON GLOMERULONEPHRITIS IN IMMUNE-COMPLEX DISEASES, Lancet, 341(8856), 1993, pp. 1353-1353
Authors:
INAGI R
MIYATA T
HONG KS
PRAMOONJAGO P
MAEDA K
INOUE K
Citation: R. Inagi et al., DECREASED ACTIVITY OF COMPLEMENT-MEDIATED IMMUNE-COMPLEX CLEARANCE INHEMODIALYSIS-PATIENTS, Clinical immunology and immunopathology, 68(3), 1993, pp. 333-339
Authors:
MIYATA T
ODA O
INAGI R
IIDA Y
ARAKI N
YAMADA N
HORIUCHI S
TANIGUCHI N
MAEDA K
KINOSHITA T
Citation: T. Miyata et al., BETA(2)-MICROGLOBULIN MODIFIED WITH ADVANCED GLYCATION END-PRODUCTS IS A MAJOR COMPONENT OF HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS, The Journal of clinical investigation, 92(3), 1993, pp. 1243-1252